Bristol/Celgene Made Perfect Sense, But Doesn’t Promise Big M&A Year, EY Says

 
• By Joseph Haas
  
Peter Behner of EY
EY Global Life Sciences Transactions Leader Peter Behner
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business